Shijin Zhang
Shijin Zhang has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
Xuewen Gong
National Engineering Research Center of Ophthalmology and Optometry, School of Biomedical Engineering, Eye Hospital
4 shared publicationsJiarong Lv
National Engineering Research Center of Ophthalmology and Optometry, School of Biomedical Engineering, Eye Hospital
3 shared publicationsQinchuan Wei
National Engineering Research Center of Ophthalmology and Optometry, School of Biomedical Engineering, Eye Hospital
3 shared publications- Wei Ji
Key Laboratory of Biorheological Science and Technology, Ministry of Education, College of Bioengineering, Chongqing University, Chongqing 400044, China
3 shared publications - Ji-Liang Li
National Engineering Research Center of Ophthalmology and Optometry, School of Biomedical Engineering, Eye Hospital, Wenzhou Medical University, Wenzhou 325027, China; University of Chinese Academy of Sciences Wenzhou Institute, Wenzhou 325001, China
2 shared publications Bingrui Wang
National Engineering Research Center of Ophthalmology and Optometry, School of Biomedical Engineering, Eye Hospital
1 shared publication
Latest Publications
- 26 February 2026
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 69 (5) , 5461-5476
ROS-Activated Peptide-Based Prodrug for Chemoselective Covalent Targeting in Cancer Cells
The development of covalent drugs has renewed interest in strategies that achieve high selectivity while minimizing off-target reactivity. Herein, we report IRS1, a peptide-based prodrug comprising an integrin-targeting RGD motif, an ROS-responsive thiomorpholine unit, and a chlorambucil-derived covalent warhead for efficient cancer inhibition. Under physiological conditions, IRS1 self-assembles into nanoparticles and preferentially accumulates in uveal melanoma (UM) cells via integrin-mediated targeting. Within the tumor microenvironment, ROS-triggered oxidation of thiomorpholine induces a hydrophobic-to-hydrophilic transition, driving the nanoparticle-to-nanofibril transformation and exposing the chlorambucil moiety. This enables covalent conjugation with the thiol groups of DR4/DR5 on the cell membrane. IRS1 effectively disrupts membrane integrity, activates extrinsic apoptosis, and induces cancer cell death in vitro. In UM xenograft models, IRS1 shows potent antitumor efficacy with reduced systemic toxicity, highlighting a peptide-reconfiguration strategy for tumor-selective covalent therapeutics.
- 26 February 2026
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 69 (5) , 5461-5476
ROS-Activated Peptide-Based Prodrug for Chemoselective Covalent Targeting in Cancer Cells
The development of covalent drugs has renewed interest in strategies that achieve high selectivity while minimizing off-target reactivity. Herein, we report IRS1, a peptide-based prodrug comprising an integrin-targeting RGD motif, an ROS-responsive thiomorpholine unit, and a chlorambucil-derived covalent warhead for efficient cancer inhibition. Under physiological conditions, IRS1 self-assembles into nanoparticles and preferentially accumulates in uveal melanoma (UM) cells via integrin-mediated targeting. Within the tumor microenvironment, ROS-triggered oxidation of thiomorpholine induces a hydrophobic-to-hydrophilic transition, driving the nanoparticle-to-nanofibril transformation and exposing the chlorambucil moiety. This enables covalent conjugation with the thiol groups of DR4/DR5 on the cell membrane. IRS1 effectively disrupts membrane integrity, activates extrinsic apoptosis, and induces cancer cell death in vitro. In UM xenograft models, IRS1 shows potent antitumor efficacy with reduced systemic toxicity, highlighting a peptide-reconfiguration strategy for tumor-selective covalent therapeutics.
- 30 April 2025
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 147 (19) , 16255-16269
Regulating the Piezoelectricity of Cyclic Dipeptide-Based Supramolecular Materials through Co-Assembly Strategy
Supramolecular co-assembly can modulate the architecture of molecular assemblies, thereby influencing their electromechanical properties. However, the relationship between supramolecular packing and electromechanical response of co-assemblies remains largely unexplored, posing a challenge in designing high-performance bioinspired piezoelectric materials. Herein, we combined experiments and theoretical calculations to systematically explore the regulation of supramolecular packing and electromechanical properties of cyclic l-aspartyl-l-aspartyl (cyclo-DD (LL))-based assemblies through co-assembling with pyridine derivatives. Crystal structures indicated that intermolecular hydrogen bonding between the carboxyl group of the cyclic dipeptide and the pyridine ring resulted in a markedly different molecular organizations and packing modes of co-assemblies. Density functional theory calculations revealed that increasing the molecular length of the pyridine derivatives enhanced the polarization effect and piezoelectric response of the cyclo-DD (LL)-based co-assemblies due to the reduced structural symmetry. Notably, the maximum piezoelectric coefficient of the cyclo-DD (LL)/4,4'-trimethylenedipyridine (TDP) co-assembly was predicted to be 140.8 pC/N, representing the highest value among peptide-based co-assemblies. Furthermore, cyclo-DD (LL)/TDP co-assembly based piezoelectric nanogenerator could generate stable open-circuit voltages over 3 V under an applied mechanical force of 50 N. For the first time, peptide-based co-assemblies were utilized as active piezoelectric materials to successfully power a display screen. Moreover, the effect of chirality on the piezoelectricity of cyclic dipeptide-based co-assemblies was investigated. This work presents an effective co-assembly strategy to manipulate the piezoelectric response of bioinspired cyclic dipeptide-based assemblies, advancing the development of high-performance piezoelectric molecular materials for sustainable energy harvesting systems.
- 30 April 2025
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 147 (19) , 16255-16269
Regulating the Piezoelectricity of Cyclic Dipeptide-Based Supramolecular Materials through Co-Assembly Strategy
Supramolecular co-assembly can modulate the architecture of molecular assemblies, thereby influencing their electromechanical properties. However, the relationship between supramolecular packing and electromechanical response of co-assemblies remains largely unexplored, posing a challenge in designing high-performance bioinspired piezoelectric materials. Herein, we combined experiments and theoretical calculations to systematically explore the regulation of supramolecular packing and electromechanical properties of cyclic l-aspartyl-l-aspartyl (cyclo-DD (LL))-based assemblies through co-assembling with pyridine derivatives. Crystal structures indicated that intermolecular hydrogen bonding between the carboxyl group of the cyclic dipeptide and the pyridine ring resulted in a markedly different molecular organizations and packing modes of co-assemblies. Density functional theory calculations revealed that increasing the molecular length of the pyridine derivatives enhanced the polarization effect and piezoelectric response of the cyclo-DD (LL)-based co-assemblies due to the reduced structural symmetry. Notably, the maximum piezoelectric coefficient of the cyclo-DD (LL)/4,4'-trimethylenedipyridine (TDP) co-assembly was predicted to be 140.8 pC/N, representing the highest value among peptide-based co-assemblies. Furthermore, cyclo-DD (LL)/TDP co-assembly based piezoelectric nanogenerator could generate stable open-circuit voltages over 3 V under an applied mechanical force of 50 N. For the first time, peptide-based co-assemblies were utilized as active piezoelectric materials to successfully power a display screen. Moreover, the effect of chirality on the piezoelectricity of cyclic dipeptide-based co-assemblies was investigated. This work presents an effective co-assembly strategy to manipulate the piezoelectric response of bioinspired cyclic dipeptide-based assemblies, advancing the development of high-performance piezoelectric molecular materials for sustainable energy harvesting systems.
- 21 March 2025
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 19 (12) , 12208-12221
Provoking Lysosome Disruption via In Situ Engineered Double-Network Assemblies for Targeted Cancer Cell Death
Increasing evidence has demonstrated the critical role of lysosomes in tumor progression, as well as their involvement in drug resistance during cancer treatment. However, the exploitation of lysosome-targeting agents to inhibit malignant cell growth is still in high demand. Herein, we report an alkaline phosphatase (ALP)-responsive peptide-based precursor (C1) that selectively induced lysosome dysfunction in uveal melanoma cells via noncontact light manipulation. We demonstrated that C1 was dephosphorylated upon close contact with ALP-upregulated tumor cells, endocytosed, and accumulated in lysosomes. Further light irradiation facilitated the generation of two self-sorting components that self-assembled to form nanofibrils and nanorods, respectively. Mesoscale interactions between these two nanostructures triggered the formation of robust double-network assemblies within lysosomes, resulting in lysosomal membrane permeabilization and tumor cell death. By strategically utilizing ALP activity, light responsiveness, and lysosomal acidity in the design of a self-assembling precursor, we have developed double-network assemblies capable of selectively disrupting lysosomal membrane integrity and effectively inhibiting tumor cells. These findings provide valuable insights for the advancement of lysosome-targeting therapeutic agents.
- 21 March 2025
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 19 (12) , 12208-12221
Provoking Lysosome Disruption via In Situ Engineered Double-Network Assemblies for Targeted Cancer Cell Death
Increasing evidence has demonstrated the critical role of lysosomes in tumor progression, as well as their involvement in drug resistance during cancer treatment. However, the exploitation of lysosome-targeting agents to inhibit malignant cell growth is still in high demand. Herein, we report an alkaline phosphatase (ALP)-responsive peptide-based precursor (C1) that selectively induced lysosome dysfunction in uveal melanoma cells via noncontact light manipulation. We demonstrated that C1 was dephosphorylated upon close contact with ALP-upregulated tumor cells, endocytosed, and accumulated in lysosomes. Further light irradiation facilitated the generation of two self-sorting components that self-assembled to form nanofibrils and nanorods, respectively. Mesoscale interactions between these two nanostructures triggered the formation of robust double-network assemblies within lysosomes, resulting in lysosomal membrane permeabilization and tumor cell death. By strategically utilizing ALP activity, light responsiveness, and lysosomal acidity in the design of a self-assembling precursor, we have developed double-network assemblies capable of selectively disrupting lysosomal membrane integrity and effectively inhibiting tumor cells. These findings provide valuable insights for the advancement of lysosome-targeting therapeutic agents.
- 10 June 2024
- Published by Elsevier in Optical Fiber Technology
- Vol. 87, 103875
Multi-objective optimization of high-power fiber laser cutting process using data augmentation-based ANN-Adam model
- 10 June 2024
- Published by Elsevier in Optical Fiber Technology
- Vol. 87, 103875
Multi-objective optimization of high-power fiber laser cutting process using data augmentation-based ANN-Adam model
- 12 July 2023
- Published by Wiley in Advanced Healthcare Materials
- Vol. 12 (21) , e2301730
Rationally Designed Enzyme‐Resistant Peptidic Assemblies for Plasma Membrane Targeting in Cancer Treatment
Peptides are being increasingly important for subcellular targeted cancer treatment to improve specificity and reverse multidrug resistance. However, there has been yet any report on targeting plasma membrane (PM) through self‐assembling peptides. A simple synthetic peptidic molecule (tF4) is developed. It is revealed that tF4 is carboxyl esterase‐resistant and self‐assembles into vesical nanostructures. Importantly, tF4 assemblies interact with PM through orthogonal hydrogen bonding and hydrophobic interaction to regulate cancer cellular functions. Mechanistically, tF4 assemblies induce stress fiber formation, cytoskeleton reconstruction, and death receptor 4/5 (DR4/5) expression in cancer cells. DR4/5 triggers extrinsic caspase‐8 signaling cascade, resulting in cell death. The results provide a new strategy for developing enzyme‐resistant and PM‐targeting peptidic molecules against cancer.
- 12 July 2023
- Published by Wiley in Advanced Healthcare Materials
- Vol. 12 (21) , e2301730
Rationally Designed Enzyme‐Resistant Peptidic Assemblies for Plasma Membrane Targeting in Cancer Treatment
Peptides are being increasingly important for subcellular targeted cancer treatment to improve specificity and reverse multidrug resistance. However, there has been yet any report on targeting plasma membrane (PM) through self‐assembling peptides. A simple synthetic peptidic molecule (tF4) is developed. It is revealed that tF4 is carboxyl esterase‐resistant and self‐assembles into vesical nanostructures. Importantly, tF4 assemblies interact with PM through orthogonal hydrogen bonding and hydrophobic interaction to regulate cancer cellular functions. Mechanistically, tF4 assemblies induce stress fiber formation, cytoskeleton reconstruction, and death receptor 4/5 (DR4/5) expression in cancer cells. DR4/5 triggers extrinsic caspase‐8 signaling cascade, resulting in cell death. The results provide a new strategy for developing enzyme‐resistant and PM‐targeting peptidic molecules against cancer.